Recombinant Human Anti-E2 Protein Antibody (TRN1001)

Provided is a fully-human-derived monoclonal antibody for neutralizing HCV (hepatitis C virus) which is capable of recognizing and combining HCV envelope protein E2. The monoclonal antibody can stop the HCV from infecting susceptible cells and is fully-human-derived, and the antibody has greatly reduced immunogenicity, good affinity, good treatment effect and low side effects as compared with other animal-derived anti-HCV molecules.
Supplier Creative Biolabs
Product # HPAB-M0060-YC
Pricing Inquiry
Host Human
Target E2 Protein
Species Reactivity HCV
Type Human IgG
Applications ELISA, Flow Cytometry, Neutralization
Feedback